Home › Cancro al seno › Connecticut › Bridgeport
Studi clinici su Cancro al seno a Bridgeport, CT
21 studi su Cancro al seno cercano partecipanti presso sedi a Bridgeport e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Stony Brook University Medical Center, Stony Brook · a 18 mi di distanza
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
In reclutamentoFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · a 18 mi di distanza
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
In reclutamentoFase 3
- Research Site, Stony Brook · a 18 mi di distanza
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
In reclutamentoFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · a 4 mi di distanza
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · a 5 mi di distanza
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
In reclutamento
- Stony Brook Cancer Center, Stony Brook · a 18 mi di distanza
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
In reclutamentoFase 1/2
- Stony Brook University Hospital, Stony Brook · a 18 mi di distanza
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
In reclutamentoFase 3
- Stony Brook University Medical Center, Stony Brook · a 18 mi di distanza
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
In reclutamentoFase 3
- Stony Brook University Cancer Center, Stony Brook · a 18 mi di distanza
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
In reclutamentoFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · a 19 mi di distanza
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · a 19 mi di distanza
- New York Cancers & Blood Specialists, Port Jefferson Station · a 19 mi di distanza
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · a 4 mi di distanza
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · a 5 mi di distanza
- e altri 1
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
In reclutamentoFase 2
- Stony Brook Cancer Center, Stony Brook · a 18 mi di distanza
ATEMPT 2.0: Adjuvant T-DM1 vs TH
In reclutamentoFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · a 4 mi di distanza
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · a 5 mi di distanza
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
In reclutamentoFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · a 19 mi di distanza
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
In reclutamentoFase 3
- Stony Brook University Cancer Center, Stony Brook · a 18 mi di distanza
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
In reclutamentoFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · a 5 mi di distanza
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
In reclutamentoFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · a 4 mi di distanza
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · a 5 mi di distanza
- Stony Brook University Medical Center, Stony Brook · a 18 mi di distanza
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
In reclutamentoStudio osservazionale
- Stony Brook Medicine, Stony Brook · a 18 mi di distanza
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
In reclutamentoFase 1 iniziale
- Stony Brook Breast Center, Stony Brook · a 18 mi di distanza
Definitive Radiation Therapy for Inoperable Breast Cancer
In reclutamento
- Stony Brook University Cancer Center, Stony Brook · a 18 mi di distanza
Definitive Radiation for High-Risk Spine Metastases
In reclutamentoFase 2
- Stony Brook University Hospital, Stony Brook · a 18 mi di distanza
CtDNA Based MRD Testing for NAC Monitoring in TNBC
In reclutamentoStudio osservazionale
- Stony Brook University Cancer Center, Stony Brook · a 18 mi di distanza
Studi su Cancro al seno in altre città
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Bridgeport
- Cancro del polmone non a piccole cellule14 studi
- Cancro ai polmoni13 studi
- Leucemia mieloide acuta12 studi
- Malattie cardiovascolari9 studi
- Cancro (tutti i tipi)8 studi
- Carcinoma a cellule squamose della testa e del collo8 studi
- Cancro metastatico7 studi
- Insufficienza cardiaca7 studi
- Aneurisma cerebrale6 studi
- Mieloma multiplo6 studi
- Cancro alla prostata6 studi
- Cancro ovarico5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.